M. A. Elliott

1.1k total citations
18 papers, 738 citations indexed

About

M. A. Elliott is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. A. Elliott has authored 18 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. A. Elliott's work include Acute Myeloid Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M. A. Elliott is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M. A. Elliott collaborates with scholars based in United States, United Kingdom and Spain. M. A. Elliott's co-authors include Ayalew Tefferi, Mark R. Litzow, Stephen M. Ansell, Luis F. Porrata, David J. Inwards, D A Gastineau, Angela Dispenzieri, Fatma Köksal Çakırlar, Curtis A. Hanson and G Dewald and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

In The Last Decade

M. A. Elliott

16 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. Elliott United States 10 442 378 260 179 61 18 738
Zhihong Wang China 14 322 0.7× 220 0.6× 138 0.5× 261 1.5× 33 0.5× 34 754
Selami Koçak Toprak Türkiye 13 81 0.2× 210 0.6× 57 0.2× 17 0.1× 149 2.4× 78 655
Naoaki Ichikawa Japan 15 235 0.5× 249 0.7× 60 0.2× 129 0.7× 152 2.5× 52 857
James McCloskey United States 13 166 0.4× 500 1.3× 370 1.4× 28 0.2× 173 2.8× 65 805
Harumi Kato Japan 15 130 0.3× 46 0.1× 95 0.4× 14 0.1× 287 4.7× 55 598
Se Lee South Korea 13 42 0.1× 237 0.6× 53 0.2× 19 0.1× 83 1.4× 27 445
Kristina Potočki Croatia 12 59 0.1× 148 0.4× 40 0.2× 504 2.8× 33 0.5× 71 874
Charles Bennett United States 5 203 0.5× 250 0.7× 31 0.1× 133 0.7× 30 0.5× 6 435
Amna Abdel‐Gadir United Kingdom 18 71 0.2× 55 0.1× 691 2.7× 120 0.7× 123 2.0× 48 1.7k

Countries citing papers authored by M. A. Elliott

Since Specialization
Citations

This map shows the geographic impact of M. A. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Elliott more than expected).

Fields of papers citing papers by M. A. Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Elliott. The network helps show where M. A. Elliott may publish in the future.

Co-authorship network of co-authors of M. A. Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Elliott. A scholar is included among the top collaborators of M. A. Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Elliott. M. A. Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Begna, Kebede H., Naseema Gangat, Hassan B. Alkhateeb, et al.. (2022). European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response. Blood Cancer Journal. 12(1). 7–7. 4 indexed citations
2.
Elliott, M. A., Louis Letendre, A Tefferi, et al.. (2011). Therapy-related acute promyelocytic leukemia (t-APL): Observations on APL pathogenesis.. Journal of Clinical Oncology. 29(15_suppl). 6567–6567. 1 indexed citations
4.
Elliott, M. A., et al.. (2009). Performance Comparison of the Biosand Filter in Laboratory Studies and a Longitudinal Field Study in Bonao, Dominican Republic. Proceedings of the Water Environment Federation. 2009(1). 584–601.
5.
Craver, Lourdes, et al.. (2009). Impact of a Pharmacist in the Outpatient Allogeneic Stem Cell Transplant Clinic. Biology of Blood and Marrow Transplantation. 15(2). 33–34. 5 indexed citations
6.
Elliott, M. A., Ayalew Tefferi, WJ Hogan, et al.. (2006). Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplantation. 37(11). 1003–1008. 47 indexed citations
7.
Elliott, M. A., et al.. (2006). Recent Progress in Slow Sand and Alternative Biofiltration Processes. 74 indexed citations
8.
Belani, Chandra P., S. Ramalingam, Anas Al-Janadi, et al.. (2006). A randomized double-blind phase II study to evaluate same-day vs next-day administration of pegfilgrastim with carboplatin and docetaxel in patients with NSCLC. Journal of Clinical Oncology. 24(18_suppl). 7110–7110. 7 indexed citations
9.
Elliott, M. A. & Ayalew Tefferi. (2005). Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. British Journal of Haematology. 128(3). 275–290. 321 indexed citations
10.
Gertz, MA, Martha Q. Lacy, Angela Dispenzieri, et al.. (2004). Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate. Bone Marrow Transplantation. 34(12). 1025–1031. 80 indexed citations
11.
Dispenzieri, Angela, Martha Q. Lacy, Mark R. Litzow, et al.. (2004). A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia. 19(1). 118–125. 33 indexed citations
12.
Elliott, M. A., Curtis A. Hanson, G Dewald, et al.. (2004). WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature. Leukemia. 19(2). 313–317. 67 indexed citations
13.
Elliott, M. A., et al.. (2000). Optical emission spectroscopic studies of microwave enhanced diamond CVD using CH 4 /CO 2 plasmas. Diamond and Related Materials. 9(3-6). 311–316. 48 indexed citations
14.
McBane, Robert D., M. A. Elliott, JG White, et al.. (2000). Fechtner syndrome: physiologic analysis of macrothrombocytopenia.. PubMed. 11(3). 243–7. 5 indexed citations
15.
Tefferi, Ayalew, M. A. Elliott, Lawrence A. Solberg, & M. N. Silverstein. (1997). New drugs in essential thrombocythemia and polycythemia vera. Blood Reviews. 11(1). 1–7. 22 indexed citations
16.
Elliott, M. A., et al.. (1997). Disseminated nocardiosis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 20(5). 425–426. 10 indexed citations
17.
Elliott, M. A.. (1987). Playing, With and Without Words. English Journal of the English Association. 36(154). 56–61.
18.
Tran, Honghi, et al.. (1986). Recovery boiler operation and plugging in Canada. TSpace. 87(7). 58–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026